Sarepta EVP has 22K shares withheld for taxes

Sarepta’s EVP and General Counsel settled RSU-related tax withholding with 22,025 shares, retaining 115,519 common shares afterward.

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. (SRPT) reported that EVP, General Counsel Cristin Rothfuss had 22,025 shares of common stock withheld on September 4, 2026 to pay tax withholding obligations arising from the vesting of restricted stock units granted on September 3, 2025. After this tax-related disposition, Rothfuss directly holds 115,519 shares of Sarepta common stock. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Tax Withholding: 22,025 shares

Tax Withholding 1 txn

Insider Rothfuss Cristin

Role EVP, General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	22,025	$22.22	$489K

Holdings After Transaction: Common Stock — 115,519 shares (Direct)

Footnotes (1)

1. F1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.

Key Figures

Shares withheld for tax: 22,025 shares Per-share value used for withholding: $22.22 per share Shares held after transaction: 115,519 shares +1 more

4 metrics

Shares withheld for tax 22,025 shares Shares withheld on September 4, 2026 to satisfy tax withholding obligations from RSU vesting

Per-share value used for withholding $22.22 per share Value reported for the 22,025 shares withheld on September 4, 2026

Shares held after transaction 115,519 shares Direct ownership of Cristin Rothfuss following the September 4, 2026 withholding

Transaction date September 4, 2026 Date of tax-withholding disposition of 22,025 shares

Key Terms

restricted stock units, tax withholding obligations, Form 4

3 terms

restricted stock units financial

"related to vesting of restricted stock units granted on September 3, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations related to vesting of restricted stock units"

Form 4 regulatory

"as reported in the Form 4 for the transaction dated September 4, 2026"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did Sarepta Therapeutics (SRPT) report for Cristin Rothfuss?

Sarepta reported that EVP, General Counsel Cristin Rothfuss had 22,025 shares of common stock withheld on September 4, 2026 to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.

Was the Sarepta (SRPT) insider transaction an open-market sale?

No. The filing states the 22,025 shares were withheld by the company to satisfy tax withholding obligations from RSU vesting, which is different from an open-market sale and is a common administrative transaction for equity awards.

How many Sarepta (SRPT) shares does Cristin Rothfuss hold after this Form 4 transaction?

After the tax-withholding disposition, Cristin Rothfuss directly holds 115,519 shares of Sarepta common stock, as reported in the Form 4 for the transaction dated September 4, 2026.

What price per share is associated with the Sarepta (SRPT) tax-withholding transaction?

The filing reports a value of $22.22 per share for the 22,025 shares withheld to satisfy tax withholding obligations related to RSU vesting on September 4, 2026.

Was the Sarepta (SRPT) insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 plan is reported for this transaction involving the withholding of 22,025 shares to cover tax obligations from RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 08:02 PM Accepted by SEC EDGAR 09/08/2026 - 08:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rothfuss Cristin

(Last) (First) (Middle)

215 FIRST STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		F(1)		22,025	D	$22.22	115,519	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.

	/s/ Cristin L. Rothfuss	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)